α-Hederin induces paraptosis by targeting GPCRs to activate Ca2+/MAPK signaling pathway in colorectal cancer

被引:6
|
作者
Rao, Xiwu [1 ,2 ,3 ,4 ]
Li, Ziwen [1 ]
Zhang, Qinchang [1 ]
Lai, Yueyang [1 ]
Liu, Jianrong [5 ]
Li, Liu [1 ]
Cheng, Haibo [1 ]
Shen, Weixing [1 ]
Sun, Dongdong [1 ]
机构
[1] Nanjing Univ Chinese Med, Collaborat Innovat Ctr Jiangsu Prov Canc Prevent &, Clin Med Coll 1, Nanjing 210023, Peoples R China
[2] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Oncol, Guangzhou, Peoples R China
[3] Guangzhou Univ Chinese Med, Guangzhou, Peoples R China
[4] Guangzhou Univ Chinese Med, Postdoctoral Res Stn, Guangzhou, Peoples R China
[5] Nanjing Univ Chinese Med, Nanjing Hosp Chinese Med, Dept Infect Dis, Nanjing, Peoples R China
来源
CANCER MEDICINE | 2024年 / 13卷 / 08期
基金
中国博士后科学基金;
关键词
calcium; colorectal cancer; MAPK; paraptosis; alpha-Hederin; Z-VAD-FMK; CELL-DEATH; PROTEIN; APOPTOSIS; SUBUNIT;
D O I
10.1002/cam4.7202
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non-apoptotic cell death is presently emerging as a potential direction to overcome the apoptosis resistance of cancer cells. In the current study, a natural plant agent alpha-hederin (alpha-hed) induces caspase-independent paraptotic modes of cell death. Purpose: The present study is aimed to investigate the role of alpha-hed induces paraptosis and the associated mechanism of it. Methods: The cell proliferation was detected by CCK-8. The cytoplasm organelles were observed under electron microscope. Calcium (Ca2+) level was detected by flow cytometry. Swiss Target Prediction tool analyzed the potential molecule targets of alpha-hed. Molecular docking methods were used to evaluate binding abilities of alpha-hed with targets. The expressions of genes and proteins were analyzed by RT-qPCR, western blotting, immunofluorescence, and immunohistochemistry. Xenograft models in nude mice were established to evaluate the anticancer effects in vivo. Results: alpha-hed exerted significant cytotoxicity against a panel of CRC cell lines by inhibiting proliferation. Besides, it induced cytoplasmic vacuolation in all CRC cells. Electron microscopy images showed the aberrant dilation of endoplasmic reticulum and mitochondria. Both mRNA and protein expressions of Alg-2 interacting proteinX (Alix), the marker of paraptosis, were inhibited by alpha-hed. Besides, both Swiss prediction and molecular docking showed that the structure of alpha-hed could tightly target to GPCRs. GPCRs were reported to activate the phospholipase C (PLC)-beta 3/ inositol 1,4,5-trisphosphate receptor (IP3R)/ Ca2+/ protein kinase C alpha (PKC alpha) pathway, and we then found all proteins and mRNA expressions of PLC beta 3, IP3R, and PKC alpha were increased by alpha-hed. After blocking the GPCR signaling, alpha-hed could not elevate Ca2+ level and showed less CRC cell cytotoxicity. MAPK cascade is the symbol of paraptosis, and we then demonstrated that alpha-hed activated MAPK cascade by elevating Ca2+ flux. Since non-apoptotic cell death is presently emerging as a potential direction to overcome chemo-drug resistance, we then found alpha-hed also induced paraptosis in 5-fluorouracil-resistant (5-FU-R) CRC cells, and it reduced the growth of 5-FU-R CRC xenografts. Conclusions: Collectively, our findings proved alpha-hed as a promising candidate for inducing non-apoptotic cell death, paraptosis. It may overcome the resistance of apoptotic-based chemo-resistance in CRC.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Therapeutic targeting of NOTCH and MAPK signaling in colorectal cancer
    Schmidt, Eva Marina
    Lamprecht, Sebastian
    Blaj, Cristina
    Krebs, Stefan
    Blum, Helmut
    Schaaf, Christian
    Hermeking, Heiko
    Jung, Andreas
    Kirchner, Thomas
    Horst, David
    LABORATORY INVESTIGATION, 2018, 98 : 300 - 301
  • [2] Therapeutic targeting of NOTCH and MAPK signaling in colorectal cancer
    Schmidt, Eva Marina
    Lamprecht, Sebastian
    Blaj, Cristina
    Krebs, Stefan
    Blum, Helmut
    Schaaf, Christian
    Hermeking, Heiko
    Jung, Andreas
    Kirchner, Thomas
    Horst, David
    MODERN PATHOLOGY, 2018, 31 : 300 - 301
  • [3] Targeting Ca2+ signaling: A new arsenal against cancer
    Panda, Suman
    Chatterjee, Oishika
    Roy, Laboni
    Chatterjee, Subhrangsu
    DRUG DISCOVERY TODAY, 2022, 27 (03) : 923 - 934
  • [4] Targeting the Wnt signaling pathway in colorectal cancer
    Sawa, Masaaki
    Masuda, Mari
    Yamada, Tesshi
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (04) : 419 - 429
  • [5] Brassinin Induces Apoptosis, Autophagy, and Paraptosis via MAPK Signaling Pathway Activation in Chronic Myelogenous Leukemia Cells
    Yang, Min Hee
    Ha, In Jin
    Lee, Seok-Geun
    Lee, Junhee
    Um, Jae-Young
    Sethi, Gautam
    Ahn, Kwang Seok
    BIOLOGY-BASEL, 2023, 12 (02):
  • [6] miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer
    Zhang, Nan
    Lu, Canrong
    Chen, Lin
    ONCOLOGY LETTERS, 2016, 12 (06) : 4589 - 4597
  • [7] ATP induces cardiomyocyte hypertrophy through the calcineurin dependent Ca2+ signaling pathway
    Uozumi, H
    Zou, Y
    Tanaka, M
    Shimoyama, M
    Hayashi, D
    Zhu, W
    Yamazaki, T
    Yazaki, Y
    CIRCULATION, 1999, 100 (18) : 628 - 628
  • [8] Phospholipase C-η1 is activated by intracellular Ca2+ mobilization and enhances GPCRs/PLC/Ca2+ signaling
    Kim, Jung Kuk
    Choi, Jung Woong
    Lim, Seyoung
    Kwon, Ohman
    Seo, Jeong Kon
    Ryu, Sung Ho
    Suh, Pann-Ghill
    CELLULAR SIGNALLING, 2011, 23 (06) : 1022 - 1029
  • [9] PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca2+ Imbalance
    Lee, Hong-Jae
    Lee, Dong-Min
    Seo, Min-Ji
    Kang, Ho-Chul
    Kwon, Seok-Kyu
    Choi, Kyeong-Sook
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [10] α -hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation
    Sun, Jian
    Feng, Yu
    Wang, Yan
    Ji, Qing
    Cai, Gang
    Shi, Lei
    Wang, Yiyi
    Huang, Yan
    Zhang, Jue
    Li, Qi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (05) : 1601 - 1612